CRAB’s Clinical Research Services (CRS) division provides our private biopharmaceutical clients with expert consulting, experienced clinical development support, and full-service clinical trial service offerings. Built upon decades of experience in cancer research, our CRS division is focused on delivering customized clinical trial strategies that exceed our client’s expectations.
As a nimble and efficient niche provider, we are the ideal partner for smaller and emerging biopharmaceutical companies who want to partner with a scientifically-oriented, oncology-focused provider. CRAB’s CRS division can provide either full-service support, or functional service offerings that are aligned with our client’s outsourcing strategy. We pride ourselves on our ability to be flexible, client-centric, and focused on helping our clients achieve their development goals.